 | • レポートコード：PMR201210 • 出版社/出版日：Persistence Market Research / 2020年9月29日 • レポート形態：英文、PDF、235ページ • 納品方法：Eメール • 産業分類：生命科学 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは抗体検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、主要成功要因、市場価値分析・予測、製品別（キット、化学薬品および試薬、消耗品）分析、効能別（妊娠、心血管疾患、自己免疫疾患、感染症、腫瘍学）分析、最終用途別（病院、学術研究所、診断研究所、バイオ製薬会社、在宅医療）分析、地域別分析、主要・新興国分析、市場構造分析、競争分析、仮定、調査手法 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・主要成功要因 ・市場価値分析・予測 ・抗体検査の世界市場規模：製品別（キット、化学薬品および試薬、消耗品） ・抗体検査の世界市場規模：疾患別（妊娠、心血管疾患、自己免疫疾患、感染症、腫瘍学） ・抗体検査の世界市場規模：最終用途別（病院、学術研究所、診断研究所、バイオ製薬会社、在宅医療） ・抗体検査の世界市場規模：地域別 ・主要・新興国分析 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Antibody Testing Market – Scope of the Report
The latest publication by Persistence Market Research (PMR) on the global antibody testing market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global antibody testing market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities of the antibody testing market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for the successful growth of the antibody testing market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers to know the demand for antibody testing and quantitative development opportunities during the study period.
The research is beneficial for shareholders in the antibody testing market, including antibody testing market investors and service providers, and can help them in developing suitable business strategies to flourish in the antibody testing market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the antibody testing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibody testing market are also included in the current study. Depending on potential developments in the antibody testing market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibody testing industry can be aided in making suitable company choices to achieve traction in the antibody testing market.
Key Questions Answered in PMR’s Antibody Testing Market Report
Which regions will continue to remain the most profitable regional markets for antibody testing market players?
Which factors will induce a change in the demand for antibody testing during the assessment period?
How will COVID-19 change the trends in the antibody testing market?
How can market players capture the low-hanging opportunities in the antibody testing market in developed regions?
What are the winning strategies of stakeholders in the antibody testing market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and tackle while investing in antibody testing market?
What are the developmental trends in antibody testing sectors that will impact the market?
How can businesses in the antibody testing market avail the growth opportunities in developed and emerging economies?
Antibody Testing Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibody testing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the antibody testing market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals, and research scholars using antibody-based test kits, and key executives of product manufacturing companies, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the antibody testing market, and makes PMR’s projections on the growth prospects of the antibody testing market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Market Evolution
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Demand Side Trends
3.2. Supply Side Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global Healthcare Outlook
4.1.2. Global Biotech and Biopharma Industry Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. Prevalence of Various Diseases
4.2.2. Historic Growth of Key Manufacturers
4.2.3. Adoption of Antibody Testing Kits
4.2.4. Product in Pipeline
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.4. COVID-19 Analysis
5. Key Success Factors
5.1. Diseases Epidemiology
5.2. Regulatory Landscape
5.3. Pipeline Assessment
5.4. Key Strategies by Manufacturer
6. Global Antibody Testing Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product, 2015–2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030
7.3.1. Kits
7.3.1.1. Serological Test Kits
7.3.1.1.1. Serological Assay Test Kits
7.3.1.1.2. Serological Rapid Assay Kits
7.3.1.2. Immunoglobulin Kits
7.3.1.2.1. Immunoglobulin Assay Test Kits
7.3.1.2.2. Immunoglobulin Rapid Assay Kits
7.3.1.3. Lateral Flow Assay Kits
7.3.1.3.1. Lateral Flow Assay Test Kits
7.3.1.3.2. Lateral Flow Rapid Assay Kits
7.3.2. Chemical and Reagents
7.3.3. Consumables
7.4. Market Attractiveness Analysis By Product Type
8. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030
8.3.1. Pregnancy
8.3.2. Cardiovascular Diseases
8.3.3. Autoimmune Diseases
8.3.4. Infectious Diseases
8.3.5. Oncology
8.3.6. Endocrine Diseases
8.3.7. Diabetes
8.3.8. Others
8.4. Market Attractiveness Analysis By Indication
9. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
9.3.1. Hospitals
9.3.2. Academic and Research Institutes
9.3.3. Diagnostic Laboratories
9.3.4. Biopharmaceutical Companies
9.3.5. Homecare Settings
9.4. Market Attractiveness Analysis By End User
10. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Indication
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants – Intensity Mapping
11.6. Drivers and Restraints – Impact Analysis
12. Latin America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By Indication
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Europe Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Product
13.3.3. By Indication
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. East Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.1.4.
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. Oceania Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Middle East and Africa Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Key and Emerging Countries Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. U.S. Antibody Testing Market Analysis
18.2.1. By Product
18.2.2. By Indication
18.2.3. By End User
18.3. Canada Antibody Testing Market Analysis
18.3.1. By Product
18.3.2. By Indication
18.3.3. By End User
18.4. Mexico Antibody Testing Market Analysis
18.4.1. By Product
18.4.2. By Indication
18.4.3. By End User
18.5. Argentina Antibody Testing Market Analysis
18.5.1. By Product
18.5.2. By Indication
18.5.3. By End User
18.6. Brazil Antibody Testing Market Analysis
18.6.1. By Product
18.6.2. By Indication
18.6.3. By End User
18.7. U.K. Antibody Testing Market Analysis
18.7.1. By Product
18.7.2. By Indication
18.7.3. By End User
18.8. Germany Antibody Testing Market Analysis
18.8.1. By Product
18.8.2. By Indication
18.8.3. By End User
18.9. France Antibody Testing Market Analysis
18.9.1. By Product
18.9.2. By Indication
18.9.3. By End User
18.10. Italy Antibody Testing Market Analysis
18.10.1. By Product
18.10.2. By Indication
18.10.3. By End User
18.11. Spain Antibody Testing Market Analysis
18.11.1. By Product
18.11.2. By Indication
18.11.3. By End User
18.12. Russia Antibody Testing Market Analysis
18.12.1. By Product
18.12.2. By Indication
18.12.3. By End User
18.13. China Antibody Testing Market Analysis
18.13.1. By Product
18.13.2. By Indication
18.13.3. By End User
18.14. Japan Antibody Testing Market Analysis
18.14.1. By Product
18.14.2. By Indication
18.14.3. By End User
18.15. South Korea Antibody Testing Market Analysis
18.15.1. By Product
18.15.2. By Indication
18.15.3. By End User
18.16. India Antibody Testing Market Analysis
18.16.1. By Product
18.16.2. By Indication
18.16.3. By End User
18.17. Indonesia Antibody Testing Market Analysis
18.17.1. By Product
18.17.2. By Indication
18.17.3. By End User
18.18. Malaysia Antibody Testing Market Analysis
18.18.1. By Product
18.18.2. By Indication
18.18.3. By End User
18.19. Australia Antibody Testing Market Analysis
18.19.1. By Product
18.19.2. By Indication
18.19.3. By End User
18.20. New Zealand Antibody Testing Market Analysis
18.20.1. By Product
18.20.2. By Indication
18.20.3. By End User
18.21. GCC Countries Antibody Testing Market Analysis
18.21.1. By Product
18.21.2. By Indication
18.21.3. By End User
18.22. Turkey Antibody Testing Market Analysis
18.22.1. By Product
18.22.2. By Indication
18.22.3. By End User
18.23. South Africa Antibody Testing Market Analysis
18.23.1. By Product
18.23.2. By Indication
18.23.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Thermo Fisher Scientific.
20.2.1.1. Company Overview
20.2.1.2. Product Overview
20.2.1.3. Profitability by Market Segments (Service/Channel/Region)
20.2.1.4. Sales Footprint
20.2.1.5. Strategy Overview
20.2.1.5.1. Marketing Strategy
20.2.1.5.2. Service Strategy
20.2.1.5.3. Channel Strategy
20.2.2. Abbott Laboratories
20.2.2.1. Company Overview
20.2.2.2. Product Overview
20.2.2.3. Profitability by Market Segments (Service/Channel/Region)
20.2.2.4. Sales Footprint
20.2.2.5. Strategy Overview
20.2.2.5.1. Marketing Strategy
20.2.2.5.2. Service Strategy
20.2.2.5.3. Channel Strategy
20.2.3. Bio-Rad Laboratories, Inc.
20.2.3.1. Company Overview
20.2.3.2. Product Overview
20.2.3.3. Profitability by Market Segments (Service/Channel/Region)
20.2.3.4. Sales Footprint
20.2.3.5. Strategy Overview
20.2.3.5.1. Marketing Strategy
20.2.3.5.2. Service Strategy
20.2.3.5.3. Channel Strategy
20.2.4. Beckton, Dickinson and Company
20.2.4.1. Company Overview
20.2.4.2. Product Overview
20.2.4.3. Profitability by Market Segments (Service/Channel/Region)
20.2.4.4. Sales Footprint
20.2.4.5. Strategy Overview
20.2.4.5.1. Marketing Strategy
20.2.4.5.2. Service Strategy
20.2.4.5.3. Channel Strategy
20.2.5. F. Hoffmann-La Roche
20.2.5.1. Company Overview
20.2.5.2. Product Overview
20.2.5.3. Profitability by Market Segments (Service/Channel/Region)
20.2.5.4. Sales Footprint
20.2.5.5. Strategy Overview
20.2.5.5.1. Marketing Strategy
20.2.5.5.2. Service Strategy
20.2.5.5.3. Channel Strategy
20.2.6. Agilent Technologies
20.2.6.1. Company Overview
20.2.6.2. Product Overview
20.2.6.3. Profitability by Market Segments (Service/Channel/Region)
20.2.6.4. Sales Footprint
20.2.6.5. Strategy Overview
20.2.6.5.1. Marketing Strategy
20.2.6.5.2. Service Strategy
20.2.6.5.3. Channel Strategy
20.2.7. DiaSorin
20.2.7.1. Company Overview
20.2.7.2. Product Overview
20.2.7.3. Profitability by Market Segments (Service/Channel/Region)
20.2.7.4. Sales Footprint
20.2.7.5. Strategy Overview
20.2.7.5.1. Marketing Strategy
20.2.7.5.2. Service Strategy
20.2.7.5.3. Channel Strategy
20.2.8. Zeus Scientific
20.2.8.1. Company Overview
20.2.8.2. Product Overview
20.2.8.3. Profitability by Market Segments (Service/Channel/Region)
20.2.8.4. Sales Footprint
20.2.8.5. Strategy Overview
20.2.8.5.1. Marketing Strategy
20.2.8.5.2. Service Strategy
20.2.8.5.3. Channel Strategy
20.2.9. Abcam
20.2.9.1. Company Overview
20.2.9.2. Product Overview
20.2.9.3. Profitability by Market Segments (Service/Channel/Region)
20.2.9.4. Sales Footprint
20.2.9.5. Strategy Overview
20.2.9.5.1. Marketing Strategy
20.2.9.5.2. Service Strategy
20.2.9.5.3. Channel Strategy
20.2.10. Trinity Biotech
20.2.10.1. Company Overview
20.2.10.2. Product Overview
20.2.10.3. Profitability by Market Segments (Service/Channel/Region)
20.2.10.4. Sales Footprint
20.2.10.5. Strategy Overview
20.2.10.5.1. Marketing Strategy
20.2.10.5.2. Service Strategy
20.2.10.5.3. Channel Strategy
20.2.11. Werfen (Biokit)
20.2.11.1. Company Overview
20.2.11.2. Product Overview
20.2.11.3. Profitability by Market Segments (Service/Channel/Region)
20.2.11.4. Sales Footprint
20.2.11.5. Strategy Overview
20.2.11.5.1. Marketing Strategy
20.2.11.5.2. Service Strategy
20.2.11.5.3. Channel Strategy
20.2.12. Promega
20.2.12.1. Company Overview
20.2.12.2. Product Overview
20.2.12.3. Profitability by Market Segments (Service/Channel/Region)
20.2.12.4. Sales Footprint
20.2.12.5. Strategy Overview
20.2.12.5.1. Marketing Strategy
20.2.12.5.2. Service Strategy
20.2.12.5.3. Channel Strategy
20.2.13. BioLegend
20.2.13.1. Company Overview
20.2.13.2. Product Overview
20.2.13.3. Profitability by Market Segments (Service/Channel/Region)
20.2.13.4. Sales Footprint
20.2.13.5. Strategy Overview
20.2.13.5.1. Marketing Strategy
20.2.13.5.2. Service Strategy
20.2.13.5.3. Channel Strategy
20.2.14. Meridian Bioscience
20.2.14.1. Company Overview
20.2.14.2. Product Overview
20.2.14.3. Profitability by Market Segments (Service/Channel/Region)
20.2.14.4. Sales Footprint
20.2.14.5. Strategy Overview
20.2.14.5.1. Marketing Strategy
20.2.14.5.2. Service Strategy
20.2.14.5.3. Channel Strategy
20.2.15. Bio-Techne (R&D Systems)
20.2.15.1. Company Overview
20.2.15.2. Product Overview
20.2.15.3. Profitability by Market Segments (Service/Channel/Region)
20.2.15.4. Sales Footprint
20.2.15.5. Strategy Overview
20.2.15.5.1. Marketing Strategy
20.2.15.5.2. Service Strategy
20.2.15.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
List of Tables:Table 01: COVID-19 Region-wise Analysis
Table 02: Pipeline Assessment of Antibody Tests
Table 03: Global Antibody Testing Market Value (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, by Product Type
Table 04: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Indication
Table 05: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by End User
Table 06: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Region
Table 07: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 08: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 09: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 10: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 11: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 12: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 13: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 14: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 15: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 16: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 17: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 18: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 19: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 20: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 21: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 22: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 23: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 24: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 25: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 26: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 27: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 28: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 29: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 30: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 31: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 32: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 33: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 34: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users